Literature DB >> 8858464

Survey of prevalence of extended spectrum beta-lactamases among enterobacteriaceae.

C Chanal1, D Sirot, J P Romaszko, L Bret, J Sirot.   

Abstract

During the first six months of 1990 and 1994 respectively, 3179 and 2721 non-repetitive strains of Enterobacteriaceae were isolated at the teaching hospital of Clermont-Ferrand. Extended-spectrum beta-lactamases were found in 147 isolates, mainly in Klebsiella pneumoniae (n = 73), Enterobacter aerogenes (n = 37) and Proteus mirabilis (n = 15). TEM-3/CTX-1, SHV-4/CAZ-5 and TEM-24/CAZ-6 were the prevalent enzymes. However, the most frequently involved enzyme in 1990 was TEM-3 (48.6%) whereas in 1994 it was SHV-4 (56.0%). Two salient features emerged from this study: the high frequency of TEM-3 production in P. mirabilis and the production of SHV-4 enzyme, heretofore observed solely in K. pneumoniae, in two other species, E. aerogenes and Escherichia coli.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8858464     DOI: 10.1093/jac/38.1.127

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  24 in total

1.  Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain.

Authors:  A Oliver; J C Pérez-Díaz; T M Coque; F Baquero; R Cantón
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  New TEM variant (TEM-92) produced by Proteus mirabilis and Providencia stuartii isolates.

Authors:  C de Champs; C Monne; R Bonnet; W Sougakoff; D Sirot; C Chanal; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

3.  Evidence of in vivo transfer of a plasmid encoding the extended-spectrum beta-lactamase TEM-24 and other resistance factors among different members of the family Enterobacteriaceae.

Authors:  C Neuwirth; E Siebor; A Pechinot; J M Duez; M Pruneaux; F Garel; A Kazmierczak; R Labia
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  TEM-24 produced by four different species of Enterobacteriaceae, including Providencia rettgeri, in a single patient.

Authors:  H Marchandin; C Carriere; D Sirot; H J Pierre; H Darbas
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

5.  A 1998 survey of extended-spectrum beta-lactamases in Enterobacteriaceae in France. The French Study Group.

Authors:  C De Champs; D Sirot; C Chanal; R Bonnet; J Sirot
Journal:  Antimicrob Agents Chemother       Date:  2000-11       Impact factor: 5.191

6.  Molecular characterization of extended-spectrum beta-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey.

Authors:  Mariagrazia Perilli; Emanuela Dell'Amico; Bernardetta Segatore; Maria Rosaria de Massis; Ciro Bianchi; Francesco Luzzaro; Gian Maria Rossolini; Antonio Toniolo; Giuseppe Nicoletti; Gianfranco Amicosante
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

7.  Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.

Authors:  Sergei Vakulenko; Dasantila Golemi
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

8.  Molecular characterization of FOX-4, a new AmpC-type plasmid-mediated beta-lactamase from an Escherichia coli strain isolated in Spain.

Authors:  G Bou; A Oliver; M Ojeda; C Monzón; J Martínez-Beltrán
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

9.  Biochemical characterization of TEM-92 extended-spectrum beta-lactamase, a protein differing from TEM-52 in the signal peptide.

Authors:  Mariagrazia Perilli; Bernardetta Segatore; Maria Rosaria De Massis; Laura Pagani; Francesco Luzzaro; Gian Maria Rossolini; Gianfranco Amicosante
Journal:  Antimicrob Agents Chemother       Date:  2002-12       Impact factor: 5.191

10.  Detection of extended-spectrum beta-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes.

Authors:  E Tzelepi; P Giakkoupi; D Sofianou; V Loukova; A Kemeroglou; A Tsakris
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.